Evonik Industries AG (EVKIY) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
EVKIY steht fuer Evonik Industries AG, ein Basic Materials-Unternehmen mit einem Kurs von $ (Marktkapitalisierung 0). Bewertet mit 39/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 16. März 2026Evonik Industries AG (EVKIY) Werkstoff- & Rohstoffexposure
Evonik Industries AG, a German-based specialty chemicals company, operates across diverse segments, providing additives, nutrition, smart materials, and performance materials. With a global presence and a focus on innovation, Evonik serves industries ranging from automotive and construction to consumer goods and healthcare, leveraging its broad product portfolio and established market position.
Investmentthese
Evonik Industries AG presents a mixed investment thesis. The company's diverse portfolio of specialty chemicals provides stability across various end markets. The dividend yield of 8.15% may attract income-focused investors. However, a profit margin of 1.9% indicates potential challenges in profitability. Future growth will depend on Evonik's ability to innovate in high-margin specialty chemicals and capitalize on growing demand in sectors like automotive and healthcare. Investors should monitor the company's ability to improve profitability and manage operational costs. The P/E ratio of 25.25 suggests the stock may be fairly valued.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market capitalization of $7.59 billion reflects Evonik's significant presence in the specialty chemicals market.
- Dividend yield of 8.15% offers an attractive income stream for investors.
- Profit margin of 1.9% indicates potential areas for improvement in operational efficiency.
- Gross margin of 23.1% demonstrates the value-added nature of Evonik's specialty chemical products.
- Beta of 0.74 suggests lower volatility compared to the broader market.
Wettbewerber & Vergleichsunternehmen
Staerken
- Diverse product portfolio across multiple segments.
- Global presence with operations in key regions.
- Strong focus on innovation and research and development.
- Established relationships with major customers in various industries.
Schwaechen
- Relatively low profit margin compared to some competitors.
- Exposure to cyclical industries such as automotive and construction.
- Dependence on raw material prices and availability.
- Complexity of managing a large and diverse organization.
Katalysatoren
- Ongoing: Expansion in the Asia-Pacific region, driven by increasing demand for specialty chemicals.
- Ongoing: Innovation in sustainable and bio-based chemicals, aligning with environmental awareness.
- Ongoing: Leveraging digital technologies to optimize operations and enhance customer engagement.
- Upcoming: Potential strategic acquisitions and partnerships to expand product portfolio and geographic reach.
- Ongoing: Increasing demand for specialty chemicals in the healthcare sector.
Risiken
- Ongoing: Intense competition from other specialty chemical companies.
- Potential: Economic downturns and fluctuations in demand.
- Potential: Regulatory changes and environmental concerns.
- Potential: Disruptions in supply chains and raw material availability.
- Ongoing: Currency risk associated with the ADR structure.
Wachstumschancen
- Growth Opportunity 1: Expansion in the Asia-Pacific region represents a significant growth opportunity for Evonik. The increasing demand for specialty chemicals in countries like China and India, driven by growing industrialization and urbanization, offers substantial market potential. Evonik can leverage its existing presence and invest in new facilities and partnerships to capitalize on this growth, targeting specific sectors like automotive and construction. This expansion could contribute significantly to revenue growth over the next 3-5 years.
- Growth Opportunity 2: Innovation in sustainable and bio-based chemicals aligns with increasing environmental awareness and regulatory pressures. Evonik can invest in research and development to create new products and solutions that meet the growing demand for sustainable alternatives. This includes developing bio-based polymers, biodegradable additives, and environmentally friendly coatings. This focus on sustainability can differentiate Evonik from competitors and attract environmentally conscious customers, driving long-term growth.
- Growth Opportunity 3: Leveraging digital technologies to optimize operations and enhance customer engagement presents a significant opportunity. Evonik can invest in digital platforms to improve supply chain management, streamline manufacturing processes, and provide customized solutions to customers. This includes using data analytics to optimize product formulations and predict customer needs. Digitalization can improve efficiency, reduce costs, and enhance customer satisfaction, driving revenue growth and profitability.
- Growth Opportunity 4: Strategic acquisitions and partnerships can expand Evonik's product portfolio and geographic reach. Evonik can target companies with complementary technologies and market access to strengthen its position in key segments. This includes acquiring companies specializing in high-growth areas like advanced materials and specialty additives. Strategic partnerships can also provide access to new markets and technologies, accelerating growth and innovation.
- Growth Opportunity 5: Increasing demand for specialty chemicals in the healthcare sector offers a promising growth avenue. Evonik can leverage its expertise in pharmaceutical polymers, amino acids, and other ingredients to develop innovative solutions for drug delivery, medical devices, and nutritional supplements. This includes developing customized formulations and providing technical support to pharmaceutical and healthcare companies. The aging global population and increasing healthcare spending are driving demand in this sector, creating significant growth opportunities for Evonik.
Chancen
- Expansion in emerging markets with high growth potential.
- Increasing demand for sustainable and bio-based chemicals.
- Leveraging digital technologies to improve efficiency and customer engagement.
- Strategic acquisitions and partnerships to expand product portfolio and market reach.
Risiken
- Intense competition from other specialty chemical companies.
- Economic downturns and fluctuations in demand.
- Regulatory changes and environmental concerns.
- Disruptions in supply chains and raw material availability.
Wettbewerbsvorteile
- Specialty chemicals expertise: Evonik's extensive knowledge and experience in specialty chemicals provide a competitive advantage.
- Diverse product portfolio: The company's broad range of products and solutions caters to various industries, reducing dependence on any single market.
- Global presence: Evonik's operations in multiple regions provide access to diverse markets and customer bases.
- Strong customer relationships: The company's focus on customized solutions and technical support fosters long-term customer relationships.
Ueber EVKIY
Founded in 1873 and headquartered in Essen, Germany, Evonik Industries AG has evolved into a leading specialty chemicals company. Originally rooted in coal and steel, the company transitioned to specialty chemicals, focusing on high-value products and solutions. Evonik operates through five segments: Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure. The Specialty Additives segment offers products like polyurethane additives and fumed silicas. The Nutrition & Care segment provides ingredients for consumer goods, animal nutrition, and healthcare. The Smart Materials segment delivers advanced materials for automotive and construction. The Performance Materials segment produces polymer materials and intermediates. The Technology & Infrastructure segment offers site management and engineering services. Evonik serves a global customer base across Asia-Pacific, Europe, the Middle East, Africa, and the Americas. As a subsidiary of RAG-Stiftung, Evonik continues to innovate and expand its portfolio of specialty chemical solutions.
Was das Unternehmen tut
- Develops and manufactures specialty additives for various industries.
- Produces nutrition and care products for consumer goods, animal nutrition, and healthcare.
- Offers smart materials for automotive, paints, coatings, adhesives, and construction sectors.
- Manufactures performance materials and intermediates for rubber, plastics, and automotive industries.
- Provides technology and infrastructure services, including site management and engineering.
- Supplies hydrogen peroxide and peracetic acid for various applications.
Geschaeftsmodell
- Evonik generates revenue by selling specialty chemicals and materials to a diverse range of industries.
- The company focuses on high-value-added products and customized solutions to meet specific customer needs.
- Evonik operates through five segments: Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure.
- The company invests in research and development to innovate new products and improve existing ones.
Branchenkontext
Evonik operates in the specialty chemicals industry, which is characterized by high value-added products and customized solutions. The industry is driven by innovation, sustainability, and increasing demand from end markets like automotive, construction, and healthcare. Competition is intense, with companies like ASGLY and BNTGF vying for market share. Market trends include a focus on sustainable and bio-based chemicals, as well as digitalization and automation in manufacturing processes. The global specialty chemicals market is expected to grow, driven by increasing demand from emerging economies and technological advancements.
Wichtige Kunden
- Automotive industry: Provides materials for vehicle manufacturing and coatings.
- Construction industry: Supplies additives for concrete, adhesives, and sealants.
- Consumer goods industry: Offers ingredients for personal care products and detergents.
- Healthcare industry: Provides pharmaceutical polymers and amino acids for drug delivery and nutrition.
Finanzdaten
Chart & Info
Evonik Industries AG (EVKIY) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer EVKIY verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer EVKIY.
Kursziele
Wall-Street-Kurszielanalyse fuer EVKIY.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von EVKIY auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Christian Kullmann
Chairman of the Executive Board
Christian Kullmann has been Chairman of the Executive Board of Evonik Industries AG since 2017. He previously held various leadership positions within the company, including Chief Strategic Officer and Head of the Advanced Intermediates Business Unit. Kullmann holds a degree in business administration from the University of Münster and has extensive experience in the chemical industry.
Erfolgsbilanz: Under Kullmann's leadership, Evonik has focused on strengthening its position in specialty chemicals and driving innovation. He has overseen strategic acquisitions and partnerships to expand the company's product portfolio and geographic reach. Kullmann has also emphasized sustainability and digitalization as key drivers of future growth.
Evonik Industries AG ADR-Informationen Nicht gesponsert
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. EVKIY is an ADR representing shares of Evonik Industries AG. This allows U.S. investors to invest in Evonik without directly dealing with foreign exchanges.
- Heimatmarkt-Ticker: Essen, DE
- ADR-Stufe: 1
- ADR-Verhaeltnis: 1:1
- Heimatmarkt-Ticker: EVKI
EVKIY OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure, may not meet minimum listing standards, and may be subject to higher risks compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks requires extra caution and due diligence.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure increases the risk of investing in EVKIY.
- Lower trading volume and wider bid-ask spreads can lead to price volatility and illiquidity.
- OTC stocks are subject to less regulatory oversight than exchange-listed stocks.
- The 'OTC Other' tier indicates a higher level of risk compared to other OTC tiers.
- Potential for fraud or manipulation is higher in the OTC market.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Check for any news articles or reports that raise red flags.
- Consult with a financial advisor before investing.
- Understand the risks associated with OTC investing.
- Evonik Industries AG is a well-established company with a long history.
- The company operates in the specialty chemicals industry, which has significant barriers to entry.
- Evonik is a subsidiary of RAG-Stiftung, a reputable organization.
- The company has a global presence and serves a diverse range of industries.
Haeufige Fragen zu EVKIY
What are the key factors to evaluate for EVKIY?
Evonik Industries AG (EVKIY) currently holds an AI score of 39/100, indicating low score. Key strength: Diverse product portfolio across multiple segments.. Primary risk to monitor: Ongoing: Intense competition from other specialty chemical companies.. This is not financial advice.
How frequently does EVKIY data refresh on this page?
EVKIY prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven EVKIY's recent stock price performance?
Recent price movement in Evonik Industries AG (EVKIY) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diverse product portfolio across multiple segments.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider EVKIY overvalued or undervalued right now?
Determining whether Evonik Industries AG (EVKIY) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying EVKIY?
Before investing in Evonik Industries AG (EVKIY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding EVKIY to a portfolio?
Potential reasons to consider Evonik Industries AG (EVKIY) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Diverse product portfolio across multiple segments.. Additionally: Global presence with operations in key regions.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of EVKIY?
Yes, most major brokerages offer fractional shares of Evonik Industries AG (EVKIY) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track EVKIY's earnings and financial reports?
Evonik Industries AG (EVKIY) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for EVKIY earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Financial data and market information are based on available sources and may be subject to change.
- The analysis provided is for informational purposes only and should not be considered investment advice.
- OTC market data may be less reliable than exchange-listed data.